First Merchants Corp Pfizer Inc Transaction History

First Merchants Corp

  • $1.42 Billion
  • Q3 2024

A detailed history of First Merchants Corp transactions in Pfizer Inc stock. As of the latest transaction made, First Merchants Corp holds 23,645 shares of PFE stock, worth $620,444. This represents 0.05% of its overall portfolio holdings.

Number of Shares
23,645
Previous 22,780 3.8%
Holding current value
$620,444
Previous $637,000 7.38%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$27.7 - $31.39 $23,960 - $27,152
865 Added 3.8%
23,645 $684,000
Q2 2024

Jul 25, 2024
SELL
$25.26 - $29.6 $9,118 - $10,685
-361 Reduced 1.56%
22,780 $637,000
Q1 2024

Apr 25, 2024
SELL
$25.89 - $29.73 $424,751 - $487,750
-16,406 Reduced 41.48%
23,141 $642,000
Q4 2023

Jan 25, 2024
SELL
$26.13 - $33.94 $3.21 Million - $4.16 Million
-122,715 Reduced 75.63%
39,547 $1.14 Million
Q3 2023

Oct 26, 2023
SELL
$32.09 - $37.51 $1.28 Million - $1.49 Million
-39,785 Reduced 19.69%
162,262 $5.38 Million
Q2 2023

Jul 25, 2023
SELL
$36.12 - $41.79 $1,408 - $1,629
-39 Reduced 0.02%
202,047 $7.41 Million
Q1 2023

Apr 25, 2023
SELL
$39.39 - $51.28 $395,554 - $514,953
-10,042 Reduced 4.73%
202,086 $8.25 Million
Q4 2022

Jan 26, 2023
BUY
$41.75 - $54.5 $705,449 - $920,886
16,897 Added 8.65%
212,128 $0
Q3 2022

Oct 25, 2022
BUY
$43.76 - $53.42 $201,689 - $246,212
4,609 Added 2.42%
195,231 $8.54 Million
Q2 2022

Jul 26, 2022
SELL
$46.53 - $55.17 $351,301 - $416,533
-7,550 Reduced 3.81%
190,622 $9.99 Million
Q1 2022

Apr 26, 2022
SELL
$45.75 - $56.69 $167,673 - $207,768
-3,665 Reduced 1.82%
198,172 $10.3 Million
Q4 2021

Jan 27, 2022
SELL
$41.32 - $61.25 $586,330 - $869,137
-14,190 Reduced 6.57%
201,837 $11.9 Million
Q3 2021

Oct 26, 2021
SELL
$39.25 - $50.42 $15,229 - $19,562
-388 Reduced 0.18%
216,027 $9.29 Million
Q2 2021

Jul 26, 2021
BUY
$35.91 - $40.68 $45,390 - $51,419
1,264 Added 0.59%
216,415 $8.47 Million
Q1 2021

Apr 22, 2021
BUY
$33.49 - $37.77 $337,847 - $381,023
10,088 Added 4.92%
215,151 $7.79 Million
Q4 2020

Jan 28, 2021
BUY
$33.47 - $42.56 $239,611 - $304,687
7,159 Added 3.62%
205,063 $7.55 Million
Q3 2020

Oct 28, 2020
BUY
$31.75 - $37.25 $666,591 - $782,063
20,995 Added 11.87%
197,904 $7.26 Million
Q2 2020

Jul 23, 2020
BUY
$30.12 - $36.54 $184,213 - $223,478
6,116 Added 3.58%
176,909 $5.79 Million
Q1 2020

Apr 23, 2020
BUY
$27.03 - $38.62 $85,874 - $122,695
3,177 Added 1.9%
170,793 $5.57 Million
Q4 2019

Jan 30, 2020
SELL
$32.92 - $37.36 $182,640 - $207,273
-5,548 Reduced 3.2%
167,616 $6.57 Million
Q3 2019

Oct 24, 2019
BUY
$32.49 - $42.13 $2.07 Million - $2.68 Million
63,679 Added 58.16%
173,164 $6.22 Million
Q2 2019

Jul 25, 2019
BUY
$36.98 - $41.52 $63,013 - $70,750
1,704 Added 1.58%
109,485 $4.74 Million
Q1 2019

Apr 25, 2019
BUY
$37.5 - $41.2 $233,100 - $256,099
6,216 Added 6.12%
107,781 $4.58 Million
Q4 2018

Jan 31, 2019
BUY
$38.47 - $43.86 $15,965 - $18,201
415 Added 0.41%
101,565 $4.43 Million
Q3 2018

Oct 24, 2018
SELL
$34.47 - $41.81 $26,162 - $31,733
-759 Reduced 0.74%
101,150 $4.46 Million
Q2 2018

Jul 26, 2018
BUY
$32.98 - $35.16 $201,969 - $215,319
6,124 Added 6.39%
101,909 $3.7 Million
Q1 2018

Apr 26, 2018
BUY
$31.91 - $37.02 $27,283 - $31,652
855 Added 0.9%
95,785 $3.4 Million
Q4 2017

Jan 30, 2018
BUY
$33.26 - $35.29 $19,157 - $20,327
576 Added 0.61%
94,930 $3.44 Million
Q3 2017

Oct 31, 2017
BUY
$31.0 - $34.15 $2.92 Million - $3.22 Million
94,354
94,354 $3.37 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.73B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Merchants Corp Portfolio

Follow First Merchants Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email